CB1R in Synthetic Psychoactive Cannabinoids

See also
Status	Clinical Trial	Phase
Completed	`NCT02564341` - Targeting Effective Analgesia in Clinics for HIV - Intervention	N/A
Completed	`NCT02224508` - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks	N/A
Completed	`NCT00593463` - Drug Discrimination in Methadone-Maintained Humans Study 1	Phase 1
Completed	`NCT03678051` - CBT4CBT for Women in Residential Treatment for Substance Use Disorders	N/A
Recruiting	`NCT04003948` - Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification	Phase 2
Withdrawn	`NCT05440721` - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification	N/A
Completed	`NCT03694327` - Innovative Digital Therapeutic for Smoking Cessation	N/A
Completed	`NCT01449981` - Development and Testing of Adolescent Twelve-Step Facilitation	N/A
Completed	`NCT00183118` - Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)	Phase 1/Phase 2
Completed	`NCT00047866` - Brain Function in Response to Motivational Stimuli	N/A
Recruiting	`NCT03333460` - Transcranial Magnetic Stimulation for Cocaine Addiction	N/A
Completed	`NCT02124980` - Automated Recovery Line for Medication Assisted Treatment	N/A
Terminated	`NCT00975416` - Oxytocin and Cognitive Behavioral Therapy in Drug Dependence	Phase 4
Completed	`NCT00265512` - LINK: Aftercare Monitoring Project	N/A
Completed	`NCT00706901` - Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans	N/A
Completed	`NCT02656745` - Clinical Trial of Smoking Cessation Mobile Phone Program	N/A
Withdrawn	`NCT00675532` - Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).	N/A
Completed	`NCT01246401` - Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations	Phase 1/Phase 2
Completed	`NCT01096550` - Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans	N/A
Completed	`NCT00605033` - A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)	Phase 4

NCT number	NCT03539575
Study type	Interventional
Source	Yale University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 1, 2018
Completion date	December 2024

CB1R in Synthetic Psychoactive Cannabinoids — CB1R in Spice

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms